{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:52:08Z","timestamp":1791229928539,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clbc.2024.03.013","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T16:38:07Z","timestamp":1711816687000},"page":"e495-e502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Introduction of Magtrace\u00ae Lymphatic Tracer for Axillary Sentinel Node Biopsy for Breast Cancer in a Rural Scottish District General Hospital: Initial Experience, Perspectives, Outcomes and Learning Curves"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-4610","authenticated-orcid":false,"given":"Chia Yew","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niroshini","family":"Hemadasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bews-Hair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clbc.2024.03.013_bib0001","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/cancers2041884","article-title":"Nanoparticles in sentinel lymph node assessment in breast cancer","volume":"2","author":"Johnson","year":"2010","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.clbc.2024.03.013_bib0002","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.1996.03540220042028","article-title":"Lymphatic mapping and sentinel node biopsy in the patient with breast cancer","volume":"276","author":"Albertini","year":"1996","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.clbc.2024.03.013_bib0003","article-title":"Anaphylactic reaction to lymphazurin 1% during breast reconstruction surgery: an uncommon but serious complication","volume":"8","author":"Krishna","year":"2020","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"2","key":"10.1016\/j.clbc.2024.03.013_bib0004","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.amjsurg.2004.06.042","article-title":"A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer","volume":"189","author":"Thevarajah","year":"2005","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.clbc.2024.03.013_bib0005","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1245\/s10434-013-3379-6","article-title":"Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG multicentre trial","volume":"21","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2024.03.013_bib0006","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.surge.2022.04.006","article-title":"Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: the UK SentiMag trial (SMART study)","volume":"21","author":"Vidya","year":"2023","journal-title":"Surgeon"},{"key":"10.1016\/j.clbc.2024.03.013_bib0007","series-title":"Magtrace and Sentimag System for Locating Sentinel Lymph Nodes for Breast Cancer Medical Technologies Guidance [MTG72]","year":"2022"},{"key":"10.1016\/j.clbc.2024.03.013_bib0008","unstructured":"NHS Dumfries and Galloway. Dumfries & Galloway Health and social care facts. 2024 Available at: https:\/\/www.nhsdg.co.uk\/getting-started-dg-facts Accessed: 30th January 2024."},{"issue":"5","key":"10.1016\/j.clbc.2024.03.013_bib0009","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jso.24164","article-title":"Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: the French SentiMag feasibility trial","volume":"113","author":"Houpeau","year":"2016","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.013_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejso.2014.11.006","article-title":"The superparamagnetic iron oxide is equivalent to the TC99 radiotracer method for identifying the sentinel lymph node in breast cancer","volume":"41","author":"Rubio","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2024.03.013_bib0011","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1245\/s10434-020-09280-1","article-title":"A pilot study evaluating the effects of Magtrace\u00ae for sentinel node biopsy in breast cancer patients regarding care process optimization, reimbursement, surgical time, and patient comfort compared with standard technetium99","volume":"28","author":"Shams","year":"2021","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"10.1016\/j.clbc.2024.03.013_bib0012","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3390\/cancers13040693","article-title":"Optimizing dose and timing in magnetic tracer techniques for sentinel lymph node detection in early breast cancers: the prospective multicenter SentiDose trial","volume":"13","author":"Hersi","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.clbc.2024.03.013_bib0013","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5152\/ejbh.2020.4730","article-title":"Extended sentinel node biopsy in breast cancer patients who achieve complete nodal response with neoadjuvant chemotherapy","volume":"16","author":"de Barros","year":"2020","journal-title":"Eur J Breast Health"},{"issue":"9","key":"10.1016\/j.clbc.2024.03.013_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105316","article-title":"Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis","volume":"9","author":"Fu","year":"2014","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.clbc.2024.03.013_bib0015","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.3390\/jcm10143149","article-title":"Superparamagnetic iron oxide for identifying sentinel lymph node in breast cancer after neoadjuvant chemotherapy: feasibility study","volume":"10","author":"Kurylcio","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.clbc.2024.03.013_bib0016","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/cancers14030676","article-title":"A propensity score matched analysis of superparamagnetic iron oxide versus radioisotope sentinel node biopsy in breast cancer patients after neoadjuvant chemotherapy","volume":"14","author":"Pelc","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924000995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924000995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T10:03:26Z","timestamp":1722074606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820924000995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1526820924000995"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2024.03.013","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Introduction of Magtrace\u00ae Lymphatic Tracer for Axillary Sentinel Node Biopsy for Breast Cancer in a Rural Scottish District General Hospital: Initial Experience, Perspectives, Outcomes and Learning Curves","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2024.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}